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Abstract
There is increasing evidence that genetic risk variants for non-syndromic cleft lip/palate
(nsCL/P) are also associated with normal-range variation in facial morphology. However,
previous analyses are mostly limited to candidate SNPs and findings have not been consis-
tently replicated. Here, we used polygenic risk scores (PRS) to test for genetic overlap
between nsCL/P and seven biologically relevant facial phenotypes. Where evidence was
found of genetic overlap, we used bidirectional Mendelian randomization (MR) to test the
hypothesis that genetic liability to nsCL/P is causally related to implicated facial phenotypes.
Across 5,804 individuals of European ancestry from two studies, we found strong evidence,
using PRS, of genetic overlap between nsCL/P and philtrum width; a 1 S.D. increase in
nsCL/P PRS was associated with a 0.10 mm decrease in philtrum width (95% C.I. 0.054,
0.146; P = 2x10-5). Follow-up MR analyses supported a causal relationship; genetic variants
for nsCL/P homogeneously cause decreased philtrum width. In addition to the primary anal-
ysis, we also identified two novel risk loci for philtrum width at 5q22.2 and 7p15.2 in our
Genome-wide Association Study (GWAS) of 6,136 individuals. Our results support a liability
threshold model of inheritance for nsCL/P, related to abnormalities in development of the
philtrum.
Author summary
Non-syndromic cleft lip/palate (nsCL/P) is a birth defect, primarily affecting the upper lip
and hard palate. Individuals with nsCL/P and their unaffected family members sometimes
present with other minor craniofacial anomalies and may have differences in facial
PLOS Genetics | https://doi.org/10.1371/journal.pgen.1007501 August 1, 2018 1 / 18
a1111111111
a1111111111
a1111111111
a1111111111
a1111111111
OPENACCESS
Citation: Howe LJ, Lee MK, Sharp GC, Davey
Smith G, St Pourcain B, Shaffer JR, et al. (2018)
Investigating the shared genetics of non-
syndromic cleft lip/palate and facial morphology.
PLoS Genet 14(8): e1007501. https://doi.org/
10.1371/journal.pgen.1007501
Editor: Heather J. Cordell, Newcastle University,
UNITED KINGDOM
Received: February 16, 2018
Accepted: June 19, 2018
Published: August 1, 2018
Copyright: © 2018 Howe et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which
permits unrestricted use, distribution, and
reproduction in any medium, provided the original
author and source are credited.
Data Availability Statement: The nsCL/P
summary statistics used in this study were
constructed using data downloaded from dbGAP.
Therefore, the authors are unable to make the
complete summary statistics publicly available
without appropriate permission. However,
replication of the analyses in the manuscript is
possible because the nsCL/P-related SNPs used
analyses are listed along with betas, standard
errors and effect alleles in the supplementary
material of the manuscript. The ICC nsCL/P
genotype dataset was obtained from dbGaP at
morphology compared to the general population. Here, we investigate the shared genetic
relationship between nsCL/P and facial morphology in a sample of around 6,000 Europe-
ans from two different studies. We demonstrate that genetic risk factors for nsCL/P are
associated with decreased philtrum width in unaffected individuals from the general pop-
ulation and that the relationship is likely causal. This finding is important because it dem-
onstrates that nsCL/P, which is often treated as a dichotomous trait, may have a
continuous dimension and offers insight into potential biological mechanisms that result
in nsCL/P.
Introduction
Orofacial clefts are malformations characterised by a failure of fusion between adjacent facial
structures in the embryo [1]. Cleft lip with/without cleft palate (CL/P) is a sub-type of orofacial
cleft, consisting of individuals presenting with a cleft of the upper lip, with or without a cleft of
the palate. Approximately 70% of CL/P cases are non-syndromic, where the facial cleft is not
accompanied by other apparent developmental or physical abnormalities [2]. The non-syndro-
mic form of CL/P (nsCL/P) is a multifactorial trait with both genetic and environmental risk
factors [1]. A possible polygenic threshold model of inheritance is supported by the identifica-
tion of more than 20 common genetic risk variants for nsCL/P from genome-wide association
studies (GWAS) [3–9] and single nucleotide polymorphism (SNP) heritability estimates of
around 30% [6].
Facial morphology in the general population is also likely to be highly polygenic; genome-
wide significant loci have been found for multiple facial phenotypes across diverse ethnic pop-
ulations [10–14]. In some cases, the genes associated with normal-range variation in facial
shape have also been implicated in nsCL/P (e.g. MAFB) [12]. Likewise, previous studies using
candidate SNPs have found overlap between nsCL/P risk loci and facial phenotypes in the gen-
eral population [11, 15, 16]. For example, the strongest nsCL/P GWAS signal, intergenic vari-
ant rs987525 on chromosome 8q24, was found to be associated with more than half of the 48
facial phenotypes studied in a European population [11] while in a Han Chinese population,
rs642961 in IRF6 (a major nsCL/P-associated gene) strongly predicted lip-shape variation in
females [16]. However, associations between nsCL/P genetic variants and facial morphology
were not consistently replicated, possibly because of methodological differences in measuring
facial phenotypes or population differences between cohorts [10].
The use of individual markers to demonstrate genetic overlap between two phenotypes has
notable limitations; a large number of statistical tests are introduced, and interpretation is dif-
ficult when some SNPs show an association and others do not. Polygenic risk scores (PRS)
involve incorporating multiple markers, including those not reaching genome-wide signifi-
cance, into a genetic score that serves as a proxy for a trait [17]. PRS have been previously
shown to be suitable predictors for nsCL/P [6] suggesting they can be used to estimate genetic
overlap between nsCL/P and normal-range facial morphology.
Interpreting genetic overlap between nsCL/P and a facial phenotype is difficult because the
development of the face and development of an orofacial cleft are largely synchronous. One
possibility is that differences in the facial phenotype are a sub-phenotypic manifestation of
genetic liability to nsCL/P (see Fig 1). The inheritance of dichotomous traits can be modelled
on the liability scale, where every individual has an underlying normally distributed liability to
the trait determined by genes, environment and chance. Individuals above a liability threshold
develop the trait, while increased liability may cause related phenotypic differences in
Shared genetics of nsCL/P and facial morphology
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individuals without the trait [18–20]. For example, increased liability to developing a cleft pal-
ate (CP) has been hypothesised to be associated with delayed movement of the palatal shelf,
which may in turn result in a CP, dependant on other factors such as shelf and head width
[20].
In order to evaluate the coherence of the liability-related sub-phenotype model, we apply
the principles of Mendelian randomization (MR). MR is an instrumental variable approach,
testing causality of an “exposure” and an outcome by using genetic instruments to mimic a
randomised controlled trial [21]. MR relies on several strict assumptions; firstly, genetic vari-
ants must be robustly associated with the exposure (in this instance, genetic liability to nsCL/
P); secondly, the variants cannot influence the outcome through a pathway independent of the
exposure; and thirdly, the variants should not be associated with confounders of the relation-
ship between the exposure and the outcome [22]. If these assumptions are met, bidirectional
MR can be used to test the hypothesis that genetic liability to nsCL/P is causally related to facial
morphology [22].
Fig 1. Liability threshold model for nsCL/P. Shown is an illustration of a liability threshold model for nsCL/P. Every individual has a normally
distributed liability to nsCL/P, determined by genes, environment and chance. Individuals over the liability threshold develop nsCL/P, with the area
under the curve past the threshold equal to the trait incidence. We are hypothesising that liability to nsCL/P, specifically genetic liability to nsCL/P, may
be associated with differences in facial morphology across the general population.
https://doi.org/10.1371/journal.pgen.1007501.g001
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In the absence of large-scale publicly available GWAS summary data for nsCL/P, we used
individual level genotype data from the International Cleft Consortium to Identify Genes and
Interactions Controlling Oral Clefts (ICC) and GWAS summary statistics from the Bonn-II
study [8] to replicate the meta-analysis GWAS summary statistics from the previously pub-
lished Ludwig et al 2012 GWAS [3]. Next, we investigated genetic overlap between nsCL/P
and normal-range facial morphology in the general population, using PRS derived from the
GWAS summary statistics. Finally, in the instance of genetic overlap, we used bidirectional
MR to explore the relationship between nsCL/P and implicated facial phenotypes. A flowchart
detailing the primary analyses is contained in Fig 2.
Results
Genome-wide association study and genetic proxy for nsCL/P
We performed a GWAS of nsCL/P using the TDT on 638 parent-offspring trios and 178 off-
spring duos of European descent, and then meta-analysed our results with GWAS summary
results previously published on 399 cases and 1,318 controls in the Bonn-II study [8]. This
yielded comparable results to a previously published GWAS [3], which used a very similar
data-set with slightly different quality control and analysis methods (S1 Table).
We also evaluated the predictive accuracy of nsCL/P that could be achieved using different
PRS constructed from these summary data by comparing the strength of association at differ-
ent inclusion thresholds of the PTDT. We determined that including independent SNPs that
surpass a P-value threshold of 10−5 was the most predictive of nsCL/P liability in both Euro-
pean and Asian trios (S2 Table). Therefore, this threshold was used for generating polygenic
risk scores from the meta-analysis summary statistics. SNPs included in the selected score are
listed in S3 Table.
The prediction of facial morphology using PRS for nsCL/P
Prior to testing the performance of our nsCL/P PRS on predicting facial morphology, we cal-
culated the minimum genetic correlation required to detect an association between the PRS
and the facial phenotypes. We found that the minimum genetic correlation required ranged
from 0.17 to 0.28 with differences attributable to different heritability estimates across the
facial phenotypes (S4 Table).
We evaluated the performance of our nsCL/P PRS for prediction of seven facial morpholog-
ical traits. Facial distances used in the analysis are shown in Fig 3. We found evidence of an
association between the nsCL/P PRS and philtrum width in the ALSPAC children, where a 1 S.
D. increase in nsCL/P PRS was associated with a 0.07 mm decrease in philtrum width (95% C.
I. 0.02, 0.13; P = 0.014) (Table 1).
We attempted to replicate this finding in the 3DFN study and found a consistent effect of 1
S.D. increase in nsCL/P PRS being associated with a 0.14 mm decrease in philtrum width (95%
C.I. 0.07, 0.21; P = 1.7x10-4). Meta-analysing these results; indicated that a 1 S.D. increase in
nsCL/P PRS is associated with a 0.10 mm decrease in philtrum width (95% C.I. 0.054, 0.146;
P = 2x10-5).
GWAS of philtrum width
To generate SNP-philtrum width association information for MR analyses, we performed
GWAS of philtrum width in both ALSPAC and 3DFN separately, before meta-analysing. The
combined sample included 6,136 individuals of recent European descent. We identified two
novel chromosomal regions associated with philtrum width with genome-wide significance at
Shared genetics of nsCL/P and facial morphology
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Fig 2. Flowchart detailing primary analyses. This figure outlines the primary analyses and data-sets in the study: 1)
the meta-analysis GWAS for nsCL/P, 2) testing the association of nsCL/P PRS with facial phenotypes in ALSPAC, 3)
attempted replication of PRS analyses in 3DFN for implicated facial phenotypes, 4) the meta-analysis GWAS for
implicated facial phenotypes and 5) bidirectional MR analyses for nsCL/P and implicated facial phenotypes.
https://doi.org/10.1371/journal.pgen.1007501.g002
Shared genetics of nsCL/P and facial morphology
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5q22.2 (lowest P value for rs255877, P = 3.8x10-10), within the non-coding RNA intronic
region of an uncategorised gene ENSG00000232633, and 7p15.2 (rs2522825, P = 1.4x10-8), an
intergenic SNP near HOXA1 (S5 Table). We found some evidence that the two lead SNPs may
be eQTLs for nearby genes (S6 Table). The two lead SNPs of the genome-wide significant loci,
rs255877 and rs2522825, were used as genetic variants associated with philtrum width in sub-
sequent MR analyses. The GWAS summary statistics are available at the University of Bristol
data repository, data.bris, at https://doi.org/10.5523/bris.1kz9y0moa8sgj2lxlk53mdmlbj [23].
Bidirectional mendelian randomization
We used MR to investigate the possible causal mechanism that would give rise to the genetic
overlap between nsCL/P and philtrum width.
Firstly, we determined whether genetic variants contributing to liability of nsCL/P cause
changes in philtrum width, by testing SNPs strongly associated with nsCL/P for association
Fig 3. Facial morphological distances of interest. This figure shows the 12 facial landmarks that were used to
generate the facial phenotypes tested for association with the nsCL/P PRS. Facial phenotypes were defined as the 3D
Euclidean distance between the following landmarks (Nasal width: 1–2, Nasal-lip distance: 3–7, Lip width: 4–5,
Philtrum width: 6–8, Lip height: 7–9, Lip-chin distance: 9–10 and inter-palpebrale width: 11–12).
https://doi.org/10.1371/journal.pgen.1007501.g003
Shared genetics of nsCL/P and facial morphology
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with philtrum width. A 1-unit log odd increase in liability to nsCL/P was associated with a
0.11mm (95% C.I. 0.04, 0.19; P = 0.0036) decrease in philtrum width. Sensitivity analyses sug-
gested there was no strong evidence for pleiotropy or heterogeneity and validated the consis-
tency of the instrument. Leave-one-SNP-out analysis showed consistent effect estimates after
exclusion of each SNP (Table 2).
Secondly, we determined whether genetic variants associated with philtrum width also
affect liability to nsCL/P, by testing two independent SNPs associated with philtrum width at
genome-wide significance (derived in the ALSPAC and 3DFN cohorts) for association with
nsCL/P. Utilising strong LD proxies (S7 Table), weak evidence was found of an association
between philtrum width-associated variants and liability to nsCL/P (LogOR = 0.30; 95% C.I.
-0.26, 0.86; P = 0.30). Sensitivity analyses for pleiotropy were limited, with only 2 SNPs.
Thirdly, we used the MR-Steiger test of directionality to test the direction of effect between
philtrum width and liability to nsCL/P. The results suggested that the true direction of effect
is that genetic variants contributing to liability to nsCL/P cause changes in philtrum width
(P<10−10).
Table 1. Association of nsCL/P PRS with facial phenotypes in ALSPAC children.
3D facial Euclidean distances in ALSPAC ALSPAC children (N = 3707)
Beta (95% C.I.) (mm) P-value
Distance between subnasale and labiale superius
(Nasal-lip)
-0.25 (-2.16, 1.65) 0.79
Distance between labiale inferius and pogonion
(Lip-chin)
-0.02 (-0.10, 0.06) 0.64
Distance between left and right palpebrale inferius (Mid-point of eyes) -0.08 (-0.17, 0.01) 0.09
Distance between left and right alare (Nasal width) -0.01 (-0.08, 0.06) 0.75
Distance between labiales inferius and superius
(lip height)
0.02 (-0.05, 0.10) 0.53
Distance between left and right crista philtri
(philtrum width)
-0.07 (-0.13, -0.02) 0.014
Distance between left and right cheilion
(lip width)
-0.02 (-0.15, 0.10) 0.70
https://doi.org/10.1371/journal.pgen.1007501.t001
Table 2. Causal estimates of genetic liability for nsCL/P on philtrum width using mendelian randomization.
Test Interpretation Estimate (95% C.I.) P-value
Inverse variance weighted Primary causal estimate1 -0.11 (-0.19, -0.04) 0.0036
Heterogeneity of Inverse variance weighted Balanced pleiotropy N/A 0.36
MR-Egger Intercept test for directional pleiotropy2 -0.01 (-0.11, 0.10) 0.93
Regression estimate1 -0.10 (-0.33, 0.13) 0.43
Weighted median Consistency1 -0.12 (-0.21, -0.04) 0.0043
Weighted mode Consistency1 -0.12 (-0.21, -0.03) 0.049
Leave-one out rs1873147 Additive model1 -0.11 (-0.20, -0.02) 0.017
Leave-one out rs227731 Additive model1 -0.10 (-0.16, -0.03) 0.007
Leave-one out rs7078160 Additive model1 -0.13 (-0.20, -0.06) 0.0001
Leave-one out rs7590268 Additive model1 -0.11 (-0.20, -0.02) 0.013
Leave-one out rs8001641 Additive model1 -0.13 (-0.21, -0.04) 0.0030
Leave-one out rs987525 Additive model1 -0.10 (-0.22, 0.01) 0.084
1 Units: mm change in philtrum width per 1-unit log odd increase in liability to nsCL/P.
2 Units: Average pleiotropic effect of a nsCL/P genetic variant on philtrum width.
https://doi.org/10.1371/journal.pgen.1007501.t002
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Interpretation of bidirectional mendelian randomization
The rationale for interpretation of the bidirectional MR analysis is contained in Fig 4. Strong
evidence was found for genetic liability to nsCL/P causing decreased philtrum width, weak evi-
dence was found for heterogeneity or assumption violations in the forward-MR, and weak evi-
dence was found for the reverse-MR of philtrum width-associated variants on liability to
nsCL/P. Therefore, we conclude that the most likely explanation for the genetic overlap
between nsCL/P and philtrum width is that genetic liability to nsCL/P is causally related to
decreased philtrum width.
Discussion
In this manuscript, we have shown that there is genetic overlap between nsCL/P and normal-
range variation in philtrum width, and furthermore, that genetic risk SNPs for nsCL/P consis-
tently cause decreased philtrum width in the general population. Notably there was weak evi-
dence for genetic overlap between nsCL/P and upper lip width despite the observational
correlation between the widths of the upper lip and philtrum.
There are two main implications of these results. First, our findings demonstrate the aetio-
logical relevance of the formation of the philtrum to nsCL/P. The medial nasal and maxillary
processes are responsible for development of the upper lip and philtrum [24]. Developmental
anomalies within these processes may result in a cleft lip [25] and our findings show that even
when there is successful fusion, as in our study populations, the genetic variants which give
rise to a CL/P cause decreased philtrum width. Secondly, the non-heterogeneous additive
effect of common nsCL/P risk variants, on a related phenotype in the general population, sup-
ports a polygenic threshold model of inheritance for nsCL/P.
Although previous studies have looked at nsCL/P related sub-phenotypes, this study uses
causal inference methods to more formally investigate the relationship. Our identification of
phenotypic differences related to nsCL/P liability are consistent with previous studies [26–31]
observing sub-clinical facial phenotypes in individuals with nsCL/P and their unaffected fam-
ily members, particularly a previous study which observed reduced philtrum width in unaf-
fected parents of individuals with nsCL/P [31]. A polygenic threshold model of inheritance
related to development of the philtrum is consistent with a previously proposed mechanism
for the inheritance of cleft palate [20], the identification of numerous common nsCL/P genetic
risk variants [3–7] and estimation of a substantial SNP heritability for nsCL/P [6]. We do not
replicate associations between nsCL/P and other facial morphological dimensions found in
previous studies [11, 15, 31] using candidate SNPs but note that polygenic risk score methods
are methodologically distinct and are used to investigate a different research question to single
SNP analyses.
We extend the investigation of the association between nsCL/P and facial morphology in
two important ways. We demonstrate that the association is present not only in unaffected
family members but also in the general population, and use MR to demonstrate that this rela-
tionship is present on the liability scale. Conventionally MR is used to test possible causal
effects of a modifiable continuous exposure such as cholesterol or alcohol on disease outcomes
[32, 33]. Here we exploit the principles of MR to test the threshold hypothesis, by inferring a
causal relationship between genetic variants contributing to liability of nsCL/P and philtrum
width in a non-clinical population. We interpret this causal relationship as evidence that
smaller philtrum width is a sub-phenotypic manifestation attributable to the same genetic vari-
ants that cause nsCL/P.
In addition to investigating the relationship between facial morphology and nsCL/P, we
also performed the first GWAS of philtrum width, and identified two novel genome-wide
Shared genetics of nsCL/P and facial morphology
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significant loci. Notably one of the loci, rs2522825 at 7p15.2, was associated with gene expres-
sion at several nearby genes in the homeobox gene family, which are known to play important
roles in embryonic development [34, 35].
The causal inference made in this study was achieved through the use of two independent
cohorts as discovery and replication samples which greatly reduces the risk of false positives
and demonstrates that results can be generalised to different populations. Detailed facial phe-
notyping data on a large number of individuals in our cohorts along with other detailed phe-
notype and genotype data enabled us to identify philtrum width as being the most relevant
facial morphological feature from amongst seven biologically likely candidates. Statistical
power does limit the detection of other features that may have mechanistic relationships with
smaller effect sizes (S4 Table).
In this study, we combined CL/P and cleft lip only (CLO), however there is evidence sug-
gesting that there are distinct aetiological differences between these traits, [5, 36, 37] which
could reduce our statistical power, and complicates interpretation. For example, the philtrum
may be more related to CLO, but we did not have sufficient data to compare nsCL/P subtype
differences. An additional limitation is that there are few well-characterised genetic risk loci
for philtrum width, so our MR analysis testing if genetic variants associated with a narrow
philtrum width also affect liability of nsCL/P, may be underpowered.
We conclude that genetic liability to nsCL/P is causally related to variation in philtrum
width and that this finding supports a polygenic threshold model of inheritance for nsCL/P,
related to abnormalities in development of the philtrum. Further research looking at the rela-
tionship between genetic liability for nsCL/P and severity of cleft would provide further evi-
dence for the polygenic threshold model.
Materials and methods
Study participants
International cleft consortium (ICC). Data were used on parent-child cleft trios from the
ICC (dbGaP Study Accession phs000094.v1.p1) [38, 39] which includes genotype data from a wide
array of geographical locations across North America, Europe and Asia. The data-set included
2,029 parent-offspring trios, 401 parent-offspring pairs, 88 single cleft cases and 25 assorted
extended families. Of the 2,543 children with an orofacial cleft; 1,988 presented with nsCL/P while
582 presented with an isolated cleft palate (CPO) and 21 presented with an “unknown cleft”.
Analysis was restricted to trios with a proband diagnosed with nsCL/P. 654 of the parent-
offspring trios and 164 of the parent-offspring pairs were of European descent and were used
in the primary analyses. 759 parent-offspring trios and 159 parent-offspring pairs of Asian
descent were included in secondary analyses.
GWAS genotypes and phenotypes are available at dbGaP (https://www.ncbi.nlm.nih.gov/
projects/gap/cgi-bin/study.cgi?study_id=phs000094.v1.p1)
Fig 4. Interpretation of bidirectional MR. (A) SNPs associated with nsCL/P have a homogeneous effect on the facial phenotype with weak evidence for the
reverse direction MR. We would conclude that genetic liability to nsCL/P causes both increased liability to nsCL/P (in conjunction with the environment
and chance) and changes in the facial phenotype. (B) SNPs associated with nsCL/P have a heterogeneous effect on the facial phenotype. In this instance, there
is weak evidence for genetic liability to nsCL/P causing changes in the facial phenotype because liability assumes a consistent effect. We would conclude
that an unknown confounder Y affects the facial phenotype and liability to nsCL/P independently. (C) SNPs associated with nsCL/P have a homogeneous
effect on the facial phenotype AND SNPs associated with the facial phenotype cause increased liability to nsCL/P. In this instance, there are two possibilities.
The first possibility is that the genetic instruments for the facial phenotype are weak (e.g. only one SNP) and so the causal effect estimate of the facial
phenotype on liability to nsCL/P is imprecise. The second possibility is that nsCL/P and the facial phenotype have a substantial genetic correlation, which
would require further investigation. Here, the results of the Steiger test are useful, as they can infer the most likely direction of effect between nsCL/P and
implicated facial phenotypes.
https://doi.org/10.1371/journal.pgen.1007501.g004
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ALSPAC. We used data on children from the Avon Longitudinal Study of Parents and
Children (ALSPAC), a longitudinal study that recruited pregnant women living in the former
county of Avon (UK) with expected delivery dates between 1 April 1991 and 31 December
1992. The initial number of enrolled pregnancies was 14,541, which resulted in 14,062 live births
and 13,988 children alive at the age of 1. When the oldest children were approximately 7 years
of age, the initial sample was boosted with eligible cases who had failed to join the study origi-
nally. For analyses of children after the age of 7, the total possible sample size is 15,247 pre-
gnancies, resulting in 14,775 live births. Full details of the enrolment have been documented
elsewhere [40, 41]. Data have been gathered from the mother and her partner (during preg-
nancy and post birth) and the children (post birth) from self-report questionnaires and clinical
sessions. Ethics approval for the study was obtained from the ALSPAC Ethics and Law Commit-
tee and the Local Research Ethics Committee. The study website contains details of all available
data through a searchable data dictionary (http://www.bristol.ac.uk/alspac/researchers/access/).
3D facial norms database. The 3D Facial Norms Database (3DFN) has been described in
detail previously [42]. In brief, we used data from the 3DFN, a database of controls for cranio-
facial research. 2,454 unrelated individuals of recent European descent aged between 3 and 40
years were recruited from 4 sites across the USA and screened for a history of craniofacial con-
ditions. 3D-derived anthropometric measurements, 3D facial surface images and genotype
data were derived from each study participant.
GWAS genotypes and phenotypes are available at dbGaP (https://www.ncbi.nlm.nih.gov/
projects/gap/cgi-bin/study.cgi?study_id=phs000949.v1.p1)).
Facial phenotyping
ALSPAC. ALSPAC children were invited to a clinic at the age of 15 years and 5,253
attended, where two high-resolution facial images were taken by Konica Minolta Vivid 900
laser scanners. 4,747 individuals had usable images (506 individuals did not complete the
assessment, or the scans were of poor quality and consequently excluded). The coordinates of
22 facial landmarks were derived from the scans. Further methodological details are contained
in a previous publication [10].
Distances between facial landmarks were computed by calculating the Euclidean distance
between the 3D coordinates. To alleviate multiple testing issues, this study chose to test 7 dis-
tances that were either tested previously or have biological relevance to nsCL/P (S8 Table).
3D facial norms database. A methodological description of the facial phenotyping has
been previously described in detail [42]. In brief, 3DFN study participants had their facial sur-
faces captured via 3D stereo-photogrammetry using either a two-pod 3dMDface or a multi-
pod 3dMDcranial system. Captures were inspected to ensure 3D surface quality and additional
captures were obtained if necessary. Similar to ALSPAC, a set of standard facial landmarks
were collected from each 3D facial image and linear distances were calculated between the
landmark coordinates.
Genotyping
ICC dbGaP. Of 7,347 DNA samples from study subjects genotyped using the Illumina
Human610_Quadv1_B array SNP genotyping platform, scans from 7,089 subjects passed QC
for unexpected relatedness, gender errors and missingness (>5%) and were released on
dbGAP (phs000094.v1.p1). Pre-dbGaP release, SNPs in sample-chromosome combinations
with a chromosomal anomaly (e.g. aneuploidy) were excluded. Post dbGaP release, SNPs were
excluded for missingness (>5%), MAF (<5%) and HWE (P < 0.05) leaving 490,493 SNPs
using PLINK [43].
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ALSPAC. A total of 9,912 ALSPAC children were genotyped using the Illumina Human-
Hap550 quad genome-wide SNP genotyping platform. Individuals were excluded from further
analysis based on having incorrect gender assignments; minimal or excessive heterozygosity
(0.345 for the Sanger data and 0.330 for the LabCorp data); disproportionate levels of individ-
ual missingness (>3%); evidence of cryptic relatedness (>10% IBD) and being of non-Euro-
pean ancestry (as detected by a multidimensional scaling analysis seeded with HapMap 2
individuals). The resulting post-quality control dataset contained 8,237 individuals. The post-
quality control ALSPAC children were combined with the ALSPAC mothers cohort (described
in detail previously [44]) and imputed together using a subset of markers common to both the
mothers and the children. The combined sample was pre-phased using ShapeIT (v2.r644) [45]
and imputed to the 1000 Genomes reference panel (Phase 1, Version3) [46] using IMPUTE3
V2.2.2 [47]. After removing SNPs with MAF (<0.1) and INFO (<0.8), genotype data were
available for 8,099,747 SNPs.
3D facial norms database. In collaboration with the Center for Inherited Disease
Research (CIDR), 2,454 subjects in the 3DFN database were genotyped using a genome-wide
association array including 964,193 SNPs from the Illumina OmniExpress+exome v1.2 array
and an additional 4,322 SNPs from previous craniofacial genetic studies. Imputation was per-
formed using the 1000 Genomes reference panel (phase 3) [42].
Statistical analysis
nsCL/P meta-analysis genome-wide association study. The transmission disequilibrium
test (TDT) [48] evaluates the frequency with which parental alleles are transmitted to affected
offspring to test genetic linkage in the presence of genetic association. The TDT was run on
638 parent-offspring trios and 178 parent-offspring duos of European descent from the ICC to
determine genome-wide genetic variation associated with nsCL/P using PLINK [43].
The Bonn-II study [8] summary statistics from a case-control GWAS of 399 nsCL/P cases
and 1,318 controls were meta-analysed, in terms of effect size and standard error, with the
TDT GWAS summary statistics using METAL [49], based on a previously described protocol
for combining TDT and case-control studies [50]. The final sample consisted of 1215 cases
and 2772 parental and unrelated controls.
Polygenic risk score analysis
P-value inclusion threshold determination and PRS construction. We started by esti-
mating the most appropriate P-value inclusion threshold for the nsCL/P PRS. The Bonn-II
study summary statistics were used to construct PRS with different P-value inclusion thresh-
olds in nsCL/P trios from the ICC. Analysis was performed separately in the Asian and Euro-
pean trios. The Polygenic-Transmission Disequilibrium Test (PTDT) [51] was then used to
measure over-transmission of polygenic risk scores from unaffected parents to affected off-
spring and thereby select the most predictive P-value inclusion threshold. The P-value inclu-
sion threshold was selected based on the most predictive threshold in the European trios, with
results from the Asian trios treated as a sensitivity analysis. Parents with any form of orofacial
cleft were removed from this analysis.
Next, using ALSPAC as a reference panel for linkage disequilibrium, PLINK was used to
prune and clump the nsCL/P meta-analysis summary statistics (r2<0.1 and 250 kb) using the
most predictive P-value threshold. The PRS were then constructed in the ALSPAC sample.
Power calculations for PRS analysis were performed using AVENGEME [17, 52]. Assuming
80% power and an alpha level of 0.05, we estimated the minimum genetic covariance required
between nsCL/P and the 3D face-shape distances, for an association between the PRS and the
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face-shape distances to be detectable. Parameters used in power calculations are contained in
S9 Table. The genetic covariance estimates were then converted to genetic correlation esti-
mates using Genome-wide complex trait analysis (GCTA) [53] heritability estimates of the
facial morphology variables derived in ALSPAC.
Association of nsCL/P PRS with facial phenotypes in ALSPAC. Of the 4,747 ALSPAC
children with face-shape scans, 3,941 individuals had genotype data. GCTA [53] was used to
prune these individuals for relatedness (IBS< 0.05) and the final sample with complete covari-
ates included 3,707 individuals. The association between facial phenotypes and the nsCL/P
PRS was measured in the final sample using a linear regression adjusted for sex, age at clinic
visit, height at clinic visit and the first four principal components. Effect sizes were reported
per standard deviation increase in PRS.
Replication in 3D facial norms database. Distances with some evidence of an association
(P< 0.05) in the ALSPAC children were followed up for replication in an independent cohort
(3DFN). 2,429 3DFN individuals had genotype and face-shape data. 332 individuals were
removed due to missing SNPs in the PRS. The final sample consisted of 2,097 individuals. The
association between implicated facial measurements and the nsCL/P PRS was measured using
a linear regression adjusted for sex, age, height and the first 4 principal components. Effect
sizes were reported per standard deviation increase in PRS.
Bidirectional mendelian randomization analysis
A bidirectional two-sample Mendelian randomization analysis was performed using the Two-
SampleMR R package [54], testing both the forward direction (the effect of genetic risk variants
for nsCL/P on implicated facial measurements) and the reverse direction (the effect of genetic
risk variants for implicated facial measurements on liability to nsCL/P). The Inverse-Variance
Weighted method was used as the primary analysis. Several sensitivity analyses were performed to
test the assumptions of MR; the heterogeneity test was used to measure balanced pleiotropy,
MR-Egger [55] was used to test for directional pleiotropy, the weighted median method [56] was
used to test if the result is consistent assuming that at least half of the variants are valid and the
weighted mode method [57] was used to test if the result is consistent assuming that the most
common effect is valid. The Steiger test [58] was used to determine the likely direction of effect.
GWAS summary statistics for nsCL/P and implicated facial phenotypes. MR analysis
required relevant SNP association information with respect to both nsCL/P and implicated
facial measurements. SNP information relevant to nsCL/P was extracted from the nsCL/P
meta-analysis summary statistics, previously described.
For implicated facial phenotypes, GWAS were performed using PLINK [43] in both
ALSPAC (3,707 individuals) and the 3DFN study (2,429 individuals with genotype and face-
shape data), using the same covariates as previously described in the polygenic risk score anal-
ysis. Summary statistics were then meta-analysed using METAL [49] with the combined sam-
ple including 6,136 individuals. SNP information relevant to implicated facial phenotypes was
then extracted from the ALSPAC/3DFN meta-analysis summary statistics.
The ALSPAC/3DFN meta-analysis GWAS summary statistics of implicated facial pheno-
types were subsequently analysed and functionally annotated [59] with the potential overlap
between philtrum-width associated SNPs and expression quantitative trait loci (eQTLs) inves-
tigated using the Genotype-Tissue Expression (GTEx) catalogue [60].
Genetic risk variants for nsCL/P and implicated facial phenotypes. For the forward
direction, genetic instruments for nsCL/P are SNPs that are strongly associated with nsCL/P. 6
well-characterised genome-wide significant nsCL/P SNPs in Europeans were taken from a pre-
vious study [3].
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Information on the 6 nsCL/P SNPs is contained in S10 Table.
For the reverse direction, genetic instruments for implicated facial phenotypes are SNPs
that are strongly associated with the implicated facial phenotypes. We LD clumped (r2<0.001
within 500KB) the ALSPAC/3DFN meta-analysis summary statistics to generate independent
instruments for the MR analysis. LD proxies (r2>0.9) were used for SNPs unavailable in the
nsCL/P summary statistics and were generated using LDlink and LDproxy [61] using the 1000
Genomes CEU/GBR populations as the reference panel [46].
Interpreting bidirectional mendelian randomization analysis. The results of the bidirec-
tional MR and relevant sensitivity analyses were used to infer the likelihood of the liability-related
sub-phenotype model. Three distinct possibilities were considered to explain the association
between nsCL/P PRS and implicated facial phenotypes (which were detailed previously in Fig 4).
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